| Featured Event |
|---|
May 1, 2013
9:20 AM ET
|
12th Annual Needham Healthcare Conference
|
| Upcoming Events |
|---|
| Details on upcoming events are not yet available. Please click here to be notified of all upcoming events. |
| Archived Events |
|---|
May 14, 2013
4:30 PM ET
|
Athersys First Quarter 2013 Results Webcast
|
Apr 17, 2013
1:15 PM ET
|
ARM's Regen Med Investor Day
The webcast link is to the YouTube feed of the Athersys talk recorded by the Alliance of Regenerative Medicine
|
Mar 12, 2013
4:30 PM ET
|
Athersys Fourth Quarter 2012 Results Webcast
|
Feb 19, 2013
9:10 AM ET
|
8th Annual New York Stem Cell Summit '13
|
Feb 12, 2013
|
15th Annual BIO CEO & Investor Conference
Speaker: Gil Van Bokkelen, PhD, Chairman and CEO
|
Jan 8, 2013
|
2013 Biotech Showcase
Speaker: Gil Van Bokkelen, PhD, Chairman and CEO
Powell Room, Parc 55 Wyndham
San Francisco, CA
|
Nov 28, 2012
3:00 PM ET
|
PiperJaffray 24th Annual HealthCare Conference
Speaker: BJ Lehmann, President and COO
|
Nov 8, 2012
4:30 PM ET
|
Athersys Third Quarter 2012 Results Webcast
|
Sep 24, 2012
1:00 PM ET
|
Noble Financial Life Sciences Exposition
|
Aug 13, 2012
4:30 PM ET
|
Athersys Second Quarter 2012 Results Webcast
|
Jun 20, 2012
8:00 AM
|
Annual Shareholder Meeting
Downtown Marriott at Key Center
127 Public Square
Cleveland, OH
The meeting will take place in the Erie conference room. A continental breakfast is available beginning at 7:30am. Attendees may valet park their vehicles and obtain a parking voucher at the meeting.
|
May 21, 2012
|
World Stem Cells & Regenerative Medicine Congress
Speaker: Gil Van Bokkelen, Chairman & CEO
Victoria Park Plaza
London
GB
Gil will be talking about identifying what should be demonstrated in successful clinical trials.
|
Feb 21, 2012
|
7th Annual New York Stem Cell Summit
Speaker: BJ Lehmann, JD, President & COO
Bridgewaters New York
11 Fulton Street
New York City, NY
Agenda: http://www.stemcellsummit.com/agenda.html
BJ's presentation is at 8:35AM
|
Feb 14, 2012
9:00 AM
|
14th Annual BIO CEO & Investor Conference
Speaker: Dr. Gil Van Bokkelen, Chairman and Chief Executive Officer
Waldorf Astoria
New York, NY
|
Feb 14, 2011
3:00 PM ET
|
13th Annual BIO CEO and Investor Conference
Speaker: Dr. Gil Van Bokkelen, Chairman and CEO
Athersys, Inc. (Nasdaq:ATHX) announced that the Company is scheduled to present at the 13th Annual BIO CEO & Investor Conference, being held February 14 and 15, 2011, at the Waldorf-Astoria Hotel in New York City.
Gil Van Bokkelen, Ph.D., Chairman and Chief Executive Officer, will provide a corporate and product development overview of the Company on Monday, February 14, 2011 at 3:30 pm EST. Investors may listen to a live audio web cast of Athersys' presentation by accessing the provided link.
|
Jan 11, 2011
10:00 AM ET
|
Retail Investor Conference Webcast
Speaker: Dr. Gil Van Bokkelen, Chairman and CEO
|
Dec 5, 2010
- Dec 7, 2010
|
BIT Life Sciences 3rd Annual World Congress of Regenerative Medicine and Stem Cells
Speaker: Dr. Robert Deans, Sr. VP, Regenerative Medicine
Location: Shanghai, China
Plenary talk: Adult Adherent Stem Cells in Treatment of Cardiovascular Injury; Development Considerations and Clinical Experience
|
Nov 30, 2010
|
22nd Annual Piper Jaffray Health Care Conference
Speaker: Dr. Gil Van Bokkelen, Chairman and CEO
New York Palace Hotel
New York City, NY
|
Nov 17, 2010
2:15 PM ET
|
Lazard Capital Markets Healthcare Conference
|
Nov 15, 2010
- Nov 16, 2010
|
5th Annual Commercial Translation for Regenerative Medicine
Speaker: Dr. Robert Deans, Sr. VP, Regenerative Medicine
Development Considerations for CNS Stem Cell Therapy
|
Oct 22, 2010
2:30 PM
|
BioCentury NewsMakers - Biotech Industry Conference
Speaker: Dr. Gil Van Bokkelen, Chairman and CEO
Gil Van Bokkelen Ph.D., Chairman and Chief Executive Officer, will present at the BioCentury NewsMakers in the Biotech Industry Conference to be held on Friday, October 22, 2010 at 2:30 PM Eastern Time at the Millennium Broadway Hotel and Conference Center in New York City.
|
Sep 22, 2010
12:15 PM
|
Transcatheter Cardiovascular Therapeutics 2010 Conference
Speaker: Marc Penn, MD, PhD, Director of the Bakken Heart-Brain Institute. Director of the Skirball Laboratory of Cardiovascular Cellular Therapeutics. Director of the Center for Cardiovascular Cell Therapy.
Washintgon, DC
Title of the talk: Preliminary Results of a Phase 1 Study with MPCs
|
Sep 20, 2010
6:00 PM
|
Marcus Evans Discovery 2010 Conference
Speaker: Dr. John Harrington, Chief Scientific Officer
Las Vegas, NV
Dr. John Harrington will be speaking at 6 PM at the Marcus Evans Discovery 2010 Conference in Las Vegas. The talk is titled "The Pharmacology of MultiStem® – A Drug-like Cell Therapy".
|
Sep 14, 2010
|
Rodman and Renshaw 12th Annual Global Healthcare Conference
Speaker: BJ Lehmann, President and COO
New York Palace Hotel
New York City, NY
William (B.J.) Lehmann, President and Chief Operating Officer, will present on Tuesday, September 14, at 4:05 PM EST.
|
Sep 13, 2010
|
Stem Cells USA Regenerative Medicine Congress
Speaker: Dr. Gil Van Bokkelen, Chairman and CEO
Radisson Plaza-Warwick Hotel
Philadelphia, PA
Gil Van Bokkelen, Ph.D., Chairman and Chief Executive Officer of Athersys will make his presentation entitled "Big Pharma and Regenerative Medicine Partnerships" on Monday, September 13, 2010 at 11:30 AM Eastern Time (ET). Dr. Van Bokkelen will address strategies for partnering with major pharmaceutical and other companies, including Athersys' partnership with Pfizer, Inc. to develop its patented and proprietary adult stem cell product MultiStem® for treatment of inflammatory bowel disease.
Dr. Van Bokkelen will also chair a panel entitled, "Autologous vs. Allogeneic Business Models" on Monday afternoon. The panel will discuss specific areas where allogeneic and autologous based therapies could be clinically and commercially relevant, and key challenges associated with the development of promising new therapies. The panel will include Dr. Devyn Smith, Senior Director, Strategic Management Group, Pfizer, Inc., Josh Hamermesh, Senior Vice President Business Development, Pervasis Therapeutics, Inc., Kenneth Aldrick, Chairman and Chief Executive Officer of International Stem Cell Corporation, and Mark Stejbach, Chief Commercial Officer, Tengion, Inc.
|
May 24, 2010
12:30 PM
|
16th Annual ISCT Meeting
Speaker: Dr. Robert Deans, Sr. VP, Regenerative Medicine
Sheraton Philadelphia City Center Hotel
Philadelphia, PA 19103
Athersys Workshop at ISCT Meeting
Emerging Technologies Supporting Dose Decisions for Adherent Stem Cell Therapies
Speakers
Dr. Robert Deans, Athersys Inc, Cleveland OH
Stem Cell Pharmacodynamics and Tissue Microarrays
Dr. David Wilson, Case Western Reserve University, Cleveland OH
Pre-Clinical Whole Body Imaging at the Level of Single Cell Detection
Dr. Eric Ahrens, Carnegie Mellon University, Pittsburgh PA
Fluorine Based Imaging Technology Bridging Pre-Clinical and Clinical Settings
|
May 12, 2010
|
World Stem Cells and Regenerative Medicine Congress
Speaker: Dr. Gil Van Bokkelen, Chairman and CEO
London
GB
Panel session: creating opportunities in the cardiovascular marketplace
|
Mar 11, 2010
|
8th World Congress on Trauma, Shock, Inflammation and Sepsis
Speaker: Dr. Robert W. Mays, Sr. Director, Regenerative Medicine
Munich
DE
Talk Title: Clinical Development of MultiStem for Treatment of Neurological Disease
|
Mar 3, 2010
- Mar 4, 2010
|
Growth and Value Investor Conference
Speaker: Dr. Gil Van Bokkelen, Chairman and CEO
Sheraton Suites Cypress Creek
555 NW 62 Street
Fort Lauderdale, AL 33309
|
Feb 16, 2010
2:20 PM
|
5th Annual Stem Cell Summit
Speaker: William (B.J.) Lehmann, JD, President & COO
|
Feb 8, 2010
1:00 PM
|
12th Annual BioCEO and Investor Conference
Speaker: Dr. Gil Van Bokkelen, Chairman and CEO
Waldorf Astoria
New York City
NY
|
 = add file to Briefcase
|
|
 |
|
May 17, 2013
4:00 PM ET
$1.86  0.02
Quotes delayed at least 20 minutes.
Information provided by eSignal.
|
|
 |
|
